Overview

This On Demand Recording was recorded live during the Medical Affairs and Scientific Communications Annual Forum.

Subsequently there may be short periods of time where the sound level may vary for any given presentation. During these short intervals, you may want to turn up the speaker volume on your computer

This session was chaired by Craig J. Klinger.

Update your knowledge on new drugs that have been approved or have been given new indications or line extensions by the FDA in 2016. A unique New Drug Comparison Rating (NDCR) system will be reviewed to allow the participant to understand the features of new drugs and explain their role among currently available therapies.

Who should attend?

Medical Communications
Medical Writing
Medical Liaisons
Medical Information
Medical Call Center Environment
Regulatory Affairs
Clinical Research
Professional Education, Training, and Development
Document Management/eSubmissions

Learning objectives

At the conclusion of this webinar, participants should be able to:

Identify the indications and routes of administration of the new therapeutic agents
Describe the important pharmacokinetic properties and the unique characteristics of the new drugs
Restate the most important adverse events and precautions of the new drugs
Compare the new drugs to the older therapeutic agents to which they are most similar in activity
Assess information regarding the new drugs that should be communicated to patients

Have an account?

New Drugs of 2015 Review And Closing Remarks

Overview

Who should attend?

Learning objectives

Be informed and stay engaged.